EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leveraging transformers and explainable AI for Alzheimer’s disease interpretability

Humaira Anzum, Nabil Sadd Sammo iD, Shamim Akhter iD

PLOS One · 23.05.2025 · 20 (5) · e0322607

DOI: 10.1371/journal.pone.0322607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 23.05.2025. Verfasst von Humaira Anzum und 2 weiteren Autor:innen. Beteiligte Einrichtung: AISIP Lab, Ahsanullah University of Science and Technology, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Alzheimer Disease, Artificial Intelligence. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive brain ailment that causes memory loss, cognitive decline, and behavioral changes. It is quite concerning that one in nine adults over the age of 65 have AD. Currently there is almost no cure for AD except very few experimental treatments. However, early detection offers chances to take part in clinical trials or other investigations looking at potential new and effective Alzheimer’s treatments. To detect Alzheimer’s disease, brain scans such as computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET) can be performed. Many researches have been undertaken to use computer vision on MRI images, and their accuracy ranges from 80–90%, new computer vision algorithms and cutting-edge transformers have the potential to improve this performance.We utilize advanced transformers and computer vision algorithms to enhance diagnostic accuracy, achieving an impressive 99% accuracy in categorizing Alzheimer’s disease stages through translating RNA text data and brain MRI images in near-real-time. We integrate the Local Interpretable Model-agnostic Explanations (LIME) explainable AI (XAI) technique to ensure the transformers’ acceptance, reliability, and human interpretability. LIME helps identify crucial features in RNA sequences or specific areas in MRI images essential for diagnosing AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseArtificial IntelligenceHumansMagnetic Resonance ImagingAlgorithmsBrainAgedMaleFemale

Autor:innen und Institutionen

  • AISIP Lab, Ahsanullah University of Science and Technology, Dhaka, Bangladesh.
  • Bangladesh University of Engineering and Technology, Dhaka, Bangladesh.

ORCID-Profile: Nabil Sadd Sammo, Shamim Akhter

Zitieren

APA

Anzum, H., Sammo, N. S., & Akhter, S. (2025). Leveraging transformers and explainable AI for Alzheimer’s disease interpretability. PLOS One, 20(5), e0322607. https://doi.org/10.1371/journal.pone.0322607

Vancouver

Anzum H, Sammo NS, Akhter S. Leveraging transformers and explainable AI for Alzheimer’s disease interpretability. PLOS One. 2025;20(5):e0322607. doi:10.1371/journal.pone.0322607

BibTeX
@article{Anzum2025,
  author = {Anzum, Humaira and Sammo, Nabil Sadd and Akhter, Shamim},
  title = {Leveraging transformers and explainable AI for Alzheimer’s disease interpretability},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {5},
  pages = {e0322607},
  doi = {10.1371/journal.pone.0322607}
}
Kostenlos starten →